Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A note on competing risks in survival data analysis.

J M Satagopan1, L Ben-Porat, M Berwick

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York 10021, USA. satagopj@mskcc.org

British Journal of Cancer
|August 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Corrigendum to "Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group": [Ann Oncol 35 (2024) 588-606].

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab.

NPJ breast cancer·2024
Same author

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Programmed intermittent epidural bolus regimen vs continuous epidural infusion: a retrospective study of motor block and obstetric outcomes using the Robson's Ten Group Classification System.

International journal of obstetric anesthesia·2024
Same author

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same journal

De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

British journal of cancer·2026
Same journal

Planetary Health Diet Index and breast cancer risk.

British journal of cancer·2026
Same journal

Can national lung cancer screening programs be implemented without exacerbating social disparities?

British journal of cancer·2026
Same journal

Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

British journal of cancer·2026
Same journal

Circulating metabolite biomarkers associated with prostate cancer risk in Black Americans: findings from the Southern Community Cohort Study.

British journal of cancer·2026
Same journal

Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use.

British journal of cancer·2026
See all related articles

Estimating cumulative incidence is crucial in survival analysis. This study highlights how competing risks, unlike non-informative censoring, require specialized methods beyond the standard Kaplan-Meier approach for accurate event probability estimation.

Area of Science:

  • Biostatistics
  • Clinical Research Methodology
  • Epidemiology

Background:

  • Survival analysis focuses on time-to-event data, with cumulative incidence estimation being a primary goal in clinical studies.
  • The Kaplan-Meier method is a standard nonparametric approach for estimating cumulative incidence, assuming non-informative censoring.
  • Competing risks, where an event other than the one of interest can occur, pose a challenge as they represent informative censoring, potentially invalidating standard methods.

Purpose of the Study:

  • To illustrate nonparametric estimation of the cumulative incidence function in the presence of competing risks.
  • To demonstrate the importance of accounting for competing events when calculating event probabilities.
  • To compare specialized competing risks methods with the traditional Kaplan-Meier approach.

Related Experiment Videos

Main Methods:

  • Nonparametric estimation techniques for the cumulative incidence function.
  • Application of methods to two published datasets containing competing risk events.
  • Comparative analysis of estimates derived from competing risks models versus Kaplan-Meier estimates.

Main Results:

  • The study demonstrates that the Kaplan-Meier method can provide biased estimates of cumulative incidence when competing risks are present.
  • Specialized methods appropriately account for informative censoring due to competing events, yielding more accurate cumulative incidence estimates.
  • The comparison highlights significant differences between the two approaches, underscoring the impact of competing risks on survival probability estimations.

Conclusions:

  • Accurate estimation of the cumulative incidence function requires explicit consideration of competing risk events.
  • The Kaplan-Meier method is not suitable for situations with informative censoring caused by competing risks.
  • Specialized statistical methods are essential for reliable survival analysis in the presence of competing risks.